TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin

December 4, 2021

In COVID-19 clinical update #91, Dr. Griffin discusses final results of molnupiravir trial, Omicron variant of concern, outcomes in B-cell depleted patients, recovery in T-cell depleted macaques, peptide for induction of T cell immunity, high respiratory viral RNA loads in infants, IgA and T cells transferred to breast milk after vaccination, sensitivity and specificity of ID NOW, post-acute sequelae at 12 months, disease in low and middle income countries.

Hosts: Daniel Griffin and Vincent Racaniello

Click arrow to play
Download TWiV 837 (25 MB .mp3, 41 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin

  1. Jennifer Dec 4, 2021

    Thank you for your explanation and concern for the rest of us. I have a question, but I’ll email it.

    Thanks again, your show should be mainstream!!

  2. Salvatore J CUCINOTTA Dec 4, 2021

    Thank you. Started listening in March 2020. You and the other scientists have helped me and my family get through this pandemic, so far. Without your help the world would be a little darker. Stay safe.

  3. Steve Blake Dec 4, 2021

    Just say protein from mutation or mutation protein.